Lord, Abbett & Co. LLC Pfizer Inc Transaction History

Lord, Abbett & Co. LLC

  • $29.9 Billion
  • Q2 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$32.09 - $37.51 $50.5 Million - $59.1 Million
-1,574,816 Reduced 63.86%
891,390 $29.6 Million
Q2 2023

Aug 14, 2023
SELL
$36.12 - $41.79 $15.6 Million - $18.1 Million
-432,990 Reduced 14.93%
2,466,206 $90.5 Million
Q1 2023

May 12, 2023
SELL
$39.39 - $51.28 $59.4 Million - $77.3 Million
-1,507,566 Reduced 34.21%
2,899,196 $118 Million
Q4 2022

Feb 10, 2023
SELL
$41.75 - $54.5 $57.2 Million - $74.7 Million
-1,369,807 Reduced 23.71%
4,406,762 $226 Million
Q3 2022

Nov 14, 2022
SELL
$43.76 - $53.42 $9 Million - $11 Million
-205,621 Reduced 3.44%
5,776,569 $253 Million
Q2 2022

Aug 12, 2022
SELL
$46.53 - $55.17 $64.7 Million - $76.7 Million
-1,389,706 Reduced 18.85%
5,982,190 $314 Million
Q1 2022

May 13, 2022
BUY
$45.75 - $56.69 $22.7 Million - $28.1 Million
495,987 Added 7.21%
7,371,896 $382 Million
Q4 2021

Feb 11, 2022
BUY
$41.32 - $61.25 $212 Million - $314 Million
5,125,851 Added 292.9%
6,875,909 $406 Million
Q3 2021

Nov 09, 2021
BUY
$39.25 - $50.42 $68.7 Million - $88.2 Million
1,750,058 New
1,750,058 $75.3 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $28.3 Million - $33.2 Million
-890,200 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$30.12 - $36.54 $74.8 Million - $90.7 Million
-2,482,262 Reduced 73.6%
890,200 $29.1 Million
Q1 2020

May 14, 2020
SELL
$27.03 - $38.62 $4.24 Million - $6.06 Million
-156,786 Reduced 4.44%
3,372,462 $110 Million
Q4 2019

Feb 14, 2020
SELL
$32.92 - $37.36 $7.19 Million - $8.16 Million
-218,301 Reduced 5.83%
3,529,248 $138 Million
Q3 2019

Nov 14, 2019
SELL
$32.49 - $42.13 $18.2 Million - $23.6 Million
-560,633 Reduced 13.01%
3,747,549 $135 Million
Q2 2019

Aug 14, 2019
SELL
$36.98 - $41.52 $55.4 Million - $62.3 Million
-1,499,345 Reduced 25.82%
4,308,182 $187 Million
Q1 2019

May 15, 2019
BUY
$37.5 - $41.2 $9.89 Million - $10.9 Million
263,649 Added 4.76%
5,807,527 $247 Million
Q4 2018

Feb 14, 2019
SELL
$38.47 - $43.86 $25.8 Million - $29.4 Million
-671,399 Reduced 10.8%
5,543,878 $242 Million
Q3 2018

Nov 14, 2018
BUY
$34.47 - $41.81 $19.7 Million - $23.9 Million
570,677 Added 10.11%
6,215,277 $274 Million
Q2 2018

Aug 14, 2018
SELL
$32.98 - $35.16 $4.63 Million - $4.94 Million
-140,400 Reduced 2.43%
5,644,600 $205 Million
Q1 2018

May 15, 2018
SELL
$31.91 - $37.02 $8.62 Million - $10 Million
-270,021 Reduced 4.46%
5,785,000 $205 Million
Q4 2017

Feb 14, 2018
SELL
$33.26 - $35.29 $30.2 Million - $32 Million
-907,233 Reduced 13.03%
6,055,021 $219 Million
Q3 2017

Nov 14, 2017
SELL
$31.0 - $34.15 $35.2 Million - $38.7 Million
-1,134,530 Reduced 14.01%
6,962,254 $249 Million
Q2 2017

Aug 14, 2017
BUY
N/A
8,096,784
8,096,784 $272 Million

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email